Trials / Completed
CompletedNCT00489606
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
Clinical Trial to Investigate the Influence of Drug Interaction After Oral Administration of Tamsulosin and SK3530 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and tamsulosin, phase I study in healthy volunteers was designed.
Detailed description
During each of the two periods of a randomized, double-blind, placebo-controlled, crossover study, 16 healthy men received tamsulosin 0.2 mg daily for 7 days and either a single 100 mg of SK3530 or placebo on day7. The blood pressure and heart rate were monitored before and for 24 hours after SK3530 or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK3530 |
Timeline
- Start date
- 2007-04-01
- Completion
- 2007-06-01
- First posted
- 2007-06-21
- Last updated
- 2007-06-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00489606. Inclusion in this directory is not an endorsement.